Results 61 to 70 of about 265 (150)

Antibiotics for acute bronchitis. [PDF]

Cochrane Database Syst Rev, 2017
Smith SM, Fahey T, Smucny J, Becker LA.
europepmc   +1 more source

Systemic and topical antibiotics for chronic rhinosinusitis. [PDF]

Cochrane Database Syst Rev, 2016
Head K, Chong LY, Piromchai P, Hopkins C, Philpott C, Schilder AG, Burton MJ.   +6 more
europepmc   +1 more source

Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials. [PDF]

Biomedicines
Sansone NMS, Boschiero MN, Marson FAL.
europepmc   +1 more source

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. [PDF]

Antimicrob Agents Chemother, 1988
Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald EJ, Fernandes PB.   +5 more
europepmc   +1 more source

Genetic diversity of macrolides resistant Staphylococcus aureus clinical isolates and the potential synergistic effect of vitamins, C and K₃. [PDF]

BMC Microbiol
El-Banna TE, Sonbol FI, Kamer AMA, Badr SAMM.   +3 more
europepmc   +1 more source

Perceived stress as a risk factor for peptic ulcers: a register-based cohort study. [PDF]

BMC Gastroenterol, 2016
Deding U, Ejlskov L, Grabas MP, Nielsen BJ, Torp-Pedersen C, Bøggild H.   +5 more
europepmc   +1 more source

In vitro interaction between cyclosporin A and macrolide antibiotics. [PDF]

Br J Clin Pharmacol, 1993
Marre F, de Sousa G, Orloff AM, Rahmani R.   +3 more
europepmc   +1 more source

Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast. [PDF]

Oncotarget, 2017
Ozsvari B, Fiorillo M, Bonuccelli G, Cappello AR, Frattaruolo L, Sotgia F, Trowbridge R, Foster R, Lisanti MP.   +8 more
europepmc   +1 more source

Lack of effect of ponsinomycin on the pharmacokinetics of nicoumalone enantiomers. [PDF]

Br J Clin Pharmacol, 1990
Couet W, Istin B, Decourt JP, Ingrand I, Girault J, Fourtillan JB.   +5 more
europepmc   +1 more source

In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferi. [PDF]

Antimicrob Agents Chemother, 1995
Cinco M, Padovan D, Stinco G, Trevisan G.   +3 more
europepmc   +1 more source